Anti-hypertensive Drugs Market By Drug Class (ACE Inhibitors, Angiotensin II Receptor Blockers, Calcium Channel Blockers, Beta Blockers, Diuretics, Renin Inhibitors, Alpha Blockers, Central Agonists and Vasodilators), By Route of Administration (Oral, Injectable, and Transdermal), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Clinics & Healthcare Facilities), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Oct 2024 | Report ID: MI1225 | 220 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Drug Class  

  • ACE Inhibitors
  • Angiotensin II Receptor Blockers
  • Calcium Channel Blockers
  • Beta Blockers
  • Diuretics
  • Renin Inhibitors
  • Alpha Blockers
  • Central Agonists
  • Vasodilators  

By Route of Administration  

  • Oral
  • Injectable
  • Transdermal

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Clinics and Healthcare Facilities

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • AstraZeneca PLC
  • Roche Holding AG
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Amgen Inc.
  • Hoffmann-La Roche AG

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing